🇺🇸 FDA
Patent

US 11834688

Ligase fusion proteins and application thereof

granted A61KA61K47/60A61K47/6801

Quick answer

US patent 11834688 (Ligase fusion proteins and application thereof) held by GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.
Grant date
Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K47/60, A61K47/6801, A61K47/68033, A61K47/6817